深圳市福田区2012年乙型肝炎病毒母婴传播阻断现况研究

doi:10.13217/j.scjpm.2013.02.045

S China J Prev Med ›› 2013, Vol. 39 ›› Issue (2): 45-47.doi: 10.13217/j.scjpm.2013.02.045

• Epidemiological Study and Investigation • Previous Articles Next Articles

Investigation on status of interrupting maternal-infant transmission of hepatitis B virus in Futian District, Shenzhen City, 2012

CAI Li, CAI Lin, DUAN Li-na, FANG Qiong, LIN Bao-ni, ZHOU Zhi-feng

Received:2012-12-25 Online:2013-04-20 Published:2013-09-23
Contact:
About author:
Supported by:

Abstract

CLC Number:

R512.62

CAI Li, CAI Lin, DUAN Li-na, FANG Qiong, LIN Bao-ni, ZHOU Zhi-feng. Investigation on status of interrupting maternal-infant transmission of hepatitis B virus in Futian District, Shenzhen City, 2012[J].S China J Prev Med, 2013, 39(2): 45-47.

[1]	. [J]. South China Journal of Preventive Medicine, 2022, 48(10): 1264-1267.
[2]	. [J]. South China Journal of Preventive Medicine, 2022, 48(7): 851-853.
[3]	. [J]. South China Journal of Preventive Medicine, 2022, 48(5): 608-610.
[4]	LIU Min-huan, ZHANG Shi-xi, WANG Cai-xia. Serum inflammatory factor levels and disease progression in patients with chronic hepatitis B virus infection [J]. South China Journal of Preventive Medicine, 2022, 48(4): 438-442.
[5]	ZHOU Cong, CHEN Qiu-yun, LIU Miao-miao. Epidemiological characteristics of hepatitis B in Yangchun City, 2009-2013 [J]. S China J Prev Med, 2016, 42(1): 58-60.
[6]	TAN Qiu, WU Cheng-gang, LIANG Jian,SHAO Xiap-ping. Family aggregation and factor analysis of HBV infection in Guangdong Province [J]. S China J Prev Med, 2014, 40(5): 468-471.
[7]	ZHONG Gui-hong, LIU Yu, SHAO Xiao-ping, ZHENG Hui-zhen. Surveillance of adverse events following hepatitis B vaccine immunization in Guangdong Province, 2009-2012 [J]. S China J Prev Med, 2014, 40(4): 380-383.
[8]	LUO Tao, PAN Hong, HOU Xing-hua, DENG Mao-ming, WU Yun-feng, GUO Yu, DUAN Lin-li, WU Nian-biao, YANG Bin.. Evaluation of MOH/GAVI project for improving timely birth dose coverage of hepatitis B vaccination in Qiandongnan, Guizhou [J]. S China J Prev Med, 2014, 40(1): 25-28.
[9]	. [J]. S China J Prev Med, 2013, 39(5): 44-45.
[10]	ZHAN Liu-hua, ZHOU Wen, XIAO Xiao-ling, DAI Liping; REN Wei; WU Xin-wei; HE Jin-hong; LI Jie-han; WU Chu-xian; LIU Fang-hua; HAO Yuan-tao. Management of integrated prevention and control of hepatitis B in community by using residential electronic health records platform [J]. S China J Prev Med, 2013, 39(4): 88-90.
[11]	FU Zhi-zhi, LV Wei, XU Wu-zhe, REN Mei-xuan．. Epidemiological characteristics of hepatitis B in Guangxi, 2005-2012 [J]. S China J Prev Med, 2013, 39(4): 20-24.
[12]	. [J]. S China J Prev Med, 2013, 39(3): 77-79.
[13]	Guangdong Provincial Center for Disease Control and Prevention. Guidelines for hepatitis B vaccination in Guangdong Province (for trial implementation) [J]. S China J Prev Med, 2013, 39(1): 92-93+97.
[14]	LI Jing, MAO Chong-shan, XIAO Er-hui, LIU Jun-ping, LU Xi-ling, PENG Zhen, LIU Cui-ping. Expression level and clinical significance of apoptosis molecules in peripheral blood mononuclear cells of patients with chronic hepatitis B [J]. South China Journal of Preventive Medicine, 2021, 47(10): 1267-1271.
[15]	HE Yan, ZHOU Yu-xia, YU Wu-bei, XU Qing-jie. Status of drug resistance in patients with chronic hepatitis B in Kaifeng City and gene mutation sites of common nucleoside （acid） drug resistance [J]. South China Journal of Preventive Medicine, 2022, 48(6): 660-664.

Investigation on status of interrupting maternal-infant transmission of hepatitis B virus in Futian District, Shenzhen City, 2012

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 0